Relapsed Malignant Solid Neoplasm
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| aur107 | PRF Technologies Ltd. (PRFX) |
Frequently asked questions
How many drugs are in development for Relapsed Malignant Solid Neoplasm?
BioSniper tracks 1 drug in development for Relapsed Malignant Solid Neoplasm across 1 company.
How many clinical trials target Relapsed Malignant Solid Neoplasm?
There are 1 clinical trial targeting Relapsed Malignant Solid Neoplasm tracked by BioSniper.
Deep-dive into Relapsed Malignant Solid Neoplasm
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis